Tisotumab Vedotin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Tisotumab Vedotin. Educational only — not medical advice.
Labeled uses
TIVDAK® is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Source: FDA labeling via NIH DailyMed (set c9fe3f32…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.